Genome-wide association of serum bilirubin levels in Korean population.

A large-scale, genome-wide association study was performed to identify genetic variations influencing serum bilirubin levels using 8841 Korean individuals. Significant associations were observed at UGT1A1 (rs11891311, P = 4.78 x 10(-148)) and SLCO1B3 (rs2417940, P = 1.03 x 10(-17)), which are two previously identified loci. The two single-nucleotide polymorphisms (SNPs) were replicated (rs11891311, P = 3.18 x 10(-15)) or marginally significant (rs2417940, P = 8.56 x 10(-4)) in an independent cohort of 1096 individuals. In a conditional analysis adjusted for the top UGT1A1 variant (rs11891311), another variant in UGT1A1 (rs4148323, P = 1.22 x 10(-121)) remained significant; this suggests that in UGT1A1 at least two independent genetic variations influence the bilirubin levels in the Korean population. The protein coding variant rs4148323, which is monomorphic in European-derived populations, may be specifically associated with serum bilirubin levels in Asians (P = 2.56 x 10(-70)). The SLCO1B3 variant (rs2417940, P = 1.67 x 10(-18)) remained significant in a conditional analysis for the top UGT1A1 variant. Interestingly, there were significant differences in the associated variations of SLCO1B3 between Koreans and European-derived populations. While the variant rs2417940 at intron 7 of SLCO1B3 was more significantly associated in Koreans, variants rs17680137 (P = 0.584) and rs2117032 (P = 2.76 x 10(-5)), two of the top-ranked SNPs in European-derived populations, did not reach the genome-wide significance level. Also, variants in SLCO1B1 did not reach genome-wide significance in Koreans. Our result supports the idea that there are considerable ethnic differences in genetic association of bilirubin levels between Koreans and European-derived populations.

[1]  Sien‐Sing Yang,et al.  Genetic factors related to unconjugated hyperbilirubinemia amongst adults , 2005, Pharmacogenetics and genomics.

[2]  Yoshiro Saito,et al.  GLUCURONIDATION OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN ( SN-38 ) , AN ACTIVE METABOLITE OF IRINOTECAN ( CPT-11 ) , BY HUMAN UGT 1 A 1 VARIANTS , 2002 .

[3]  D. Keppler,et al.  ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. , 1997, The Biochemical journal.

[4]  G. Abecasis,et al.  Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. , 2009, Human Molecular Genetics.

[5]  M. Kaito,et al.  Linkage disequilibrium of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms. , 2006, Oncology Report.

[6]  C. Gui,et al.  Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  P. Wilson,et al.  Evidence for a gene influencing serum bilirubin on chromosome 2q telomere: a genomewide scan in the Framingham study. , 2003, American journal of human genetics.

[8]  Yoshiro Saito,et al.  Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[9]  K. Yamamoto,et al.  A case of anorexia nervosa with hyperbilirubinaemia in a patient homozygous for a mutation in the bilirubin UDP-glucuronosyltransferase gene , 1999, European Journal of Pediatrics.

[10]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[11]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[12]  Rui F. M. Silva,et al.  Bilirubin toxicity to human erythrocytes: a review. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[13]  Ming-Huei Chen,et al.  Genome-wide association meta-analysis for total serum bilirubin levels. , 2009, Human molecular genetics.

[14]  J. Crawford,et al.  Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells. , 1991, The Journal of biological chemistry.

[15]  D Lindhout,et al.  The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. , 1995, The New England journal of medicine.

[16]  Andrew D. Johnson,et al.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..

[17]  P. Bosma,et al.  Molecular biology of bilirubin metabolism. , 1995, Progress in liver diseases.

[18]  Taesung Park,et al.  A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits , 2009, Nature Genetics.

[19]  D W Nebert,et al.  The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. , 1997, Pharmacogenetics.

[20]  Y. Sugiyama,et al.  Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[21]  Wei Zhang,et al.  OATP1B1 POLYMORPHISM IS A MAJOR DETERMINANT OF SERUM BILIRUBIN LEVEL BUT NOT ASSOCIATED WITH RIFAMPICIN‐MEDIATED BILIRUBIN ELEVATION , 2007, Clinical and experimental pharmacology & physiology.

[22]  J. Miners,et al.  Multiple pharmacophores for the investigation of human UDP-glucuronosyltransferase isoform substrate selectivity. , 2004, Molecular pharmacology.

[23]  Jacques Fellay,et al.  WGAViewer: software for genomic annotation of whole genome association studies. , 2008, Genome research.

[24]  Wei Chen,et al.  SNP@Evolution: a hierarchical database of positive selection on the human genome , 2009, BMC Evolutionary Biology.